每經AI快訊，大理(li)藥業(ye)（SH 603963，收盤價(jia)：14.99元）12月7日晚間發布公(gong)(gong)告稱，控(kong)(kong)股(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)東及(ji)(ji)其他股(gu)(gu)(gu)(gu)(gu)東持股(gu)(gu)(gu)(gu)(gu)的基本(ben)(ben)情(qing)況：截至本(ben)(ben)公(gong)(gong)告披露(lu)日，大理(li)藥業(ye)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)有(you)(you)限公(gong)(gong)司(si)(si)(si)控(kong)(kong)股(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)東、實(shi)際控(kong)(kong)制人(ren)、董事(shi)長、總(zong)(zong)(zong)經理(li)楊(yang)(yang)君祥(xiang)先(xian)生(sheng)持有(you)(you)公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約(yue)5602萬(wan)股(gu)(gu)(gu)(gu)(gu)，占(zhan)公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總(zong)(zong)(zong)數的25.5%；公(gong)(gong)司(si)(si)(si)董事(shi)楊(yang)(yang)君衛先(xian)生(sheng)持有(you)(you)公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約(yue)165萬(wan)股(gu)(gu)(gu)(gu)(gu)，占(zhan)公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總(zong)(zong)(zong)數的0.75%。楊(yang)(yang)君祥(xiang)先(xian)生(sheng)、楊(yang)(yang)君衛先(xian)生(sheng)持有(you)(you)的股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)來(lai)源于(yu)(yu)公(gong)(gong)司(si)(si)(si)首次公(gong)(gong)開發行(xing)前取得的股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)及(ji)(ji)資本(ben)(ben)公(gong)(gong)積(ji)轉增股(gu)(gu)(gu)(gu)(gu)本(ben)(ben)方式(shi)(shi)(shi)取得的股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)，該股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)已于(yu)(yu)2020年(nian)9月22日解除(chu)限售并(bing)上(shang)市(shi)流(liu)通。楊(yang)(yang)君祥(xiang)先(xian)生(sheng)因(yin)自身(shen)資金需求擬(ni)通過(guo)集中(zhong)競價(jia)及(ji)(ji)/或大宗交易方式(shi)(shi)(shi)合(he)計(ji)減(jian)持公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總(zong)(zong)(zong)數不(bu)超過(guo)約(yue)659萬(wan)股(gu)(gu)(gu)(gu)(gu)，減(jian)持比例不(bu)超過(guo)公(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的3%，減(jian)持價(jia)格(ge)(ge)根據市(shi)場價(jia)格(ge)(ge)確(que)定；楊(yang)(yang)君衛先(xian)生(sheng)因(yin)自身(shen)資金需求擬(ni)通過(guo)集中(zhong)競價(jia)及(ji)(ji)/或大宗交易方式(shi)(shi)(shi)合(he)計(ji)減(jian)持公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總(zong)(zong)(zong)數不(bu)超過(guo)約(yue)41萬(wan)股(gu)(gu)(gu)(gu)(gu)，減(jian)持比例不(bu)超過(guo)公(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的0.1875%，減(jian)持價(jia)格(ge)(ge)根據市(shi)場價(jia)格(ge)(ge)確(que)定。楊(yang)(yang)君祥(xiang)先(xian)生(sheng)、楊(yang)(yang)君衛先(xian)生(sheng)合(he)計(ji)擬(ni)通過(guo)集中(zhong)競價(jia)及(ji)(ji)/或大宗交易方式(shi)(shi)(shi)合(he)計(ji)減(jian)持公(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總(zong)(zong)(zong)數不(bu)超過(guo)約(yue)700萬(wan)股(gu)(gu)(gu)(gu)(gu)，減(jian)持比例不(bu)超過(guo)公(gong)(gong)司(si)(si)(si)總(zong)(zong)(zong)股(gu)(gu)(gu)(gu)(gu)本(ben)(ben)的約(yue)3.19%。

2021年1至12月份，大理(li)藥(yao)業(ye)的營業(ye)收入構成為(wei)：醫藥(yao)制造業(ye)占(zhan)比99.72%，醫藥(yao)商業(ye)占(zhan)比0.27%。

大理藥業的(de)董(dong)事長、總(zong)經(jing)理均是楊君祥，男，60歲，學歷背(bei)景為(wei)中專。

截至發稿，大理藥業市(shi)值(zhi)為33億元。

道達號（daoda1997）“個(ge)股(gu)趨勢”提醒：
1. 近30日內無機構對大理藥業進行調研。
更(geng)多個股趨勢信息，請搜索(suo)微信公(gong)眾號“道達號”，回復(fu)“查詢”，領取(qu)免費(fei)查詢權限！

每(mei)經頭(tou)條(tiao)（nbdtoutiao）——

(記者 曾健輝)

免責聲明：本文內容與(yu)數(shu)據僅供參考，不構(gou)成投資建(jian)議，使用前請核實。據此操作，風險自擔。